Skip to main content

and
  1. No Access

    Article

    Tanshinone IIA (TSIIA) represses the progression of non-small cell lung cancer by the circ_0020123/miR-1299/HMGB3 pathway

    Tanshinone IIA (TSIIA), a multi-pharmaceutical compound, has been demonstrated to have anti-tumor properties. This study explores the potential regulatory mechanism of TSIIA on non-small cell lung cancer (NSCL...

    Fei Sun, **aoli Yang, Wei Song, Nan Yu, Qingyi Lin in Molecular and Cellular Biochemistry (2023)